Belinda Baum

BELINDA BAUM advises pharmaceutical, biotechnology, medical device, and food companies on complex EU regulatory and litigation matters, with a particular focus on pharmaceutical law, digital health, and emerging EU legislation. She regularly advises clients in proceedings before the European Union courts, as well as in their interactions with EU regulatory authorities.

Belinda is active in Sidley’s pharmacovigilance benchmarking group and co-leads the Digital, Device, Diagnostics Legal Roundtable, a forum that brings together in-house counsel and regulators to discuss emerging legal developments affecting the MedTech sector.

Belinda holds an LL.M. in national and global health law from Georgetown University. Before joining Sidley, she gained experience at the European Commission (DG SANTE) and at the German Federal Ministry of Food and Agriculture, advising on EU regulatory and public health matters.

Belinda’s recent experience includes advising:

• DocMorris, Redcare and the European Association of E-Pharmacies (EAEP) on a variety of EU law and policy matters relating to restrictions of cross-border online sales of medicinal products.
• A European pharmaceutical company on urgent, high-value regulatory matters relating to the marketing authorization of its lead product in the European Union.
• A pharmaceutical company in proceedings before the General Court concerning the marketing authorization of medicinal products in the European Union.
• Pharmaceutical companies on pharmacovigilance, advertising and promotion, Swiss regulatory requirements, and the optimization of supply chain and distribution models.
• Pharmaceutical, biotechnology and medical device companies on a broad range of EU regulatory matters, including the AI Act, the European Health Data Space (EHDS), the revised Product Liability Directive (PLD), the Packaging and Packaging Waste Regulation (PPWR), and the EU pharmaceutical reform package.
• An American multinational medical devices and healthcare company on a number of key regulatory matters, this includes classification and compliance for its new diagnostic device which involved a complex analysis of how artificial intelligence and machine learning may impact the current medical device framework.
• A food company in proceedings before the General Court concerning the EU framework governing smoke flavoring authorizations.
• A leading food supplements company on the use of health and nutrition claims under EU food law.
• Food and consumer products companies on EU food labelling requirements, including product presentation and mandatory information obligations.
• Manufacturers on regulatory requirements relating to food contact materials under EU law.
• Companies and industry associations on the regulatory implications of the proposed harmonized classification of talc under the EU Classification, Labelling and Packaging (CLP) Regulation.

• German Women Lawyer’s Association (Deutscher Juristinnenbund)

 

During her internship with the Campaign for Tobacco-Free Kids in Washington, D.C., Belinda carried out pro bono work, where she advised on regulatory matters, tobacco control laws of several countries and human rights non-binding recommendations for tobacco control and food policies.